| 261 |
Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study |
2008 |
| 262 |
Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study |
2008 |
| 263 |
Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
|
2008 |
| 264 |
Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. |
2008 |
| 265 |
Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. |
2008 |
| 266 |
Re-evaluation of Primary Congenital Hypothyroidism using Tc-99m Thyroid Scan. |
2007 |
| 267 |
Factor V leiden and antiphospholipid antibodies in pregnancies complicated by preclampsia |
2007 |
| 268 |
Factor V leiden and antiphospholipid antibodies in pregnancies complicated by preclampsia |
2007 |
| 269 |
Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings.
|
2006 |
| 270 |
Human Melanoma Cells Release Soluble and Functional Receptors |
2006 |
